Meeting
2015 ASCO Annual Meeting
A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI).
Authors
David B. Page
Memorial Sloan Kettering Cancer Center, New York, NY
David B. Page , Veronica Mariotti , Oksana Davydov , Sujata Patil , Didier Hans , Clifford A. Hudis , Azeez Farooki , Monica Nancy Fornier
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 33, 2015 (suppl; abstr 574)
DOI
10.1200/jco.2015.33.15_suppl.574
Abstract #
574
Poster Bd #
62
Abstract Disclosures
Similar Posters
Poster
2014 Breast Cancer Symposium
Screening and treatment of osteoporosis in breast cancer survivors treated with aromatase inhibitors: Gap between the national guidelines and real-world practice.
First Author: Sukriti Kamboj
Poster
2024 ASCO Annual Meeting
Predicting completion of endocrine therapy for older patients with early-stage breast cancer.
First Author: Jerome Karp
Poster
2022 ASCO Quality Care Symposium
Bone health program: A community cancer center's experience.
First Author: Manasa Anipindi
Poster
2020 ASCO Virtual Scientific Program
Rates of adherence to bone health guidelines for women with breast cancer treated with anti-estrogen therapy.
First Author: Leighton Andrew Elliott